Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: SG who wrote (1429)	3/14/2000 8:12:00 PM
From: Bruce Wysocki	Respond to of 1501

Hold tight it looks like 3i did buy shares: chart.canada-stockwatch.com

To: SG who wrote (1429)	3/15/2000 10:38:00 PM
From: Bob Schommer	Read Replies (2) \| Respond to of 1501

SG et al: While I trade some issues I don't want to lose my position in IZP despite the recent genomic buffeting. We all know why we bought and as they say, true value always wins out in the end. Phase II for Apanol is just ahead and we may indeed be sitting on a novel anti-inflammatory franchise. When to sell? Maybe never on this company. I will at least wait for definitive phase trial results before I pull the trigger. To borrow a word from Churchill: "Now is not the end; it is not even the beginning of the end. It is, perhaps, the end of the beginning." Take the long view on this one. Regards, Bob